10:14 AM EST - Aptose Biosciences Inc. : Will provide a clinical update on Monday, October 30, 2023, in conjunction with poster presentations at the European School of Haematology (ESH) 6th International Conference: Acute Myeloid Leukemia "Molecular and Translational": Advances in Biology and Treatment, being held October. Aptose Biosciences Inc.
shares T.APS are trading up $0.08 at $3.20.
